Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year
Hypertension March 8, 2021 Otto Simonsson, Peter S. Hendricks, Robin Carhart‐Harris et al. 36 citations
Adults who had used a classic psychedelic at least once in their lifetime had 14% lower odds of hypertension in the past year, after adjusting for confounders. The association was strongest for tryptamine psychedelics (DMT, ayahuasca, psilocybin), which were linked to 20% lower odds of hypertension. No significant association was found for LSD or mescaline. The authors note these findings are correlational and call for randomized controlled trials to test causal effects.